I. Pavord (Leicester, United Kingdom)
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD
M. Cazzola, M. G. Matera (Naples, Italy)
|  |
Effect of theophylline in low and average doses on lung function and quality of life in patients with COPD
A. Altymysheva, T. Sooronbaev (Bishkek, Kyrgyzstan)
| |
Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients
C. M. Tranfa, C. Cesaro, N. Crispino, E. Grella, V. Guarriello (Naples, Italy)
| |
Management of severe COPD cases in an outpatients department
I. G. Stoica (Bucharest, Romania)
| |
Replacing oxytropium with tiotropium significantly improves pulmonary function in patients with COPD
C. Pravettoni, C. Incorvaia, G. G. Riario Sforza (Milan, Italy)
| |
Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease
E. A. Petukhova, J. N. Krasnova, A. A. Dzizinskii (Irkutsk, Russian Federation)
| |
A comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a double-blind, efficacy and safety study in Chinese adults with chronic obstructive pulmonary disease (COPD)
T. C. Y. Tsao, M. L. Chuang, C. H. Chen, Y. H. Tsai (Taipei, Taiwan, Province Of China)
| |
The effect of topical ophthalmic timolol in patients treated for COPD with inhaled beta adrenergic agonist albuterol
M. J. Ledina, L. A. Ledina, T. M. Ledina (Sokobanja, Belgrade, Serbia And Montenegro)
| |
Rational timing of combination therapy with tiotropium and formoterol in moderate-severe COPD
C. Terzano, A. Petroianni (Rome, Italy)
| |
Budesonide/formoterol has an onset of action that is similar to salbutamol and faster than salmeterol/fluticasone in patients with COPD
A. Lindberg, Z. Szalai, T. Pullerits, E. Radeczky (Lulea, Gothenburg, Sweden; Mosonmagyarovar, Szazhalombatta, Hungary)
| |
Budesonide/formoterol (B/F) as maintenance and relief for asthma improves efficacy and is cost-saving versus a higher maintenance dose of B/F or salmeterol/fluticasone (S/F)
D. Price, A. Wiren, P. Kuna (Aberdeen, United Kingdom; Lund, Sweden; Lodz, Poland)
| |
Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease
S. Sunmez, E. Kiyan, G. Okumus, O. Arseven, T. Ece, H. Issever (Istanbul, Turkey)
| |
Efficacy of nebulized arformoterol, a long-acting β2-adrenergic bronchodilator, in patients with COPD
J. P. Hanrahan, S. A. Sahn, W. W. Busse, K. Sciarappa, R. A. Baumgartner (Marlborough, Charleston, Madison, United States Of America)
| |
Addition of theophylline to standard inhalatory therapy in patients with stable COPD: effects on exercise tolerance
F. Di Marco, A. Pistone, M. Mondoni, P. Santus, P. Carlucci, B. Boveri, S. Centanni (Milano, Italy)
| |
A comparison of the effects of lung function between low dose theophylline and oral β2-agonist in patients with chronic obstructive pulmonary disease
N. Kishimoto, H. Nakamura, N. Nanki, T. Kamei, S. Tada, N. Ueda (Takamatsu, Shikoku, Japan)
| |
Clinical efficacy of transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophyline
T. Kinoshita, T. Kawayama, T. Hoshino, S. Minami, M. Ichiki, M. Nishiyama, Y. Sueyasu, R. Gohara, M. Kinoshita, T. Mitsui, H. Koga, H. Aizawa (Kurume, Japan)
| |
Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients
Y. Tp, M. Ito, I. M. Adcock, P. J. Barnes, S. A. Kharitonov, K. Ito (London, United Kingdom)
| |
The effect of oral corticosteroid on spirometeric parameters in COPD patients induced by mustard gas
E. Eidani, A. Farajzadeh Sheikh, F. Sharifi Pour, A. Jolodar, G. Ahmadi (Ahwaz, Islamic Republic Of Iran)
| |
Volumeresponse in non-reversible airway obstruction: a proof of concept study
A. M. Balestra, J. D. Leuppi, M. Tamm, R. B. Bingisser (Basel, Switzerland)
| |
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS)
P. Tegou, S. Markantonis, A. Amfilochiou, V. Tsagaraki (Athens, Greece)
| |